THE DIFFERENT LIPID LOWERING TARGET BY STATINS FOR JAPANESE TO PREVENT CARDIOVASCULAR EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTIONS

被引：0
|
作者：
Sakamoto, T. [1 ]
Ogawa, H. [2 ]
机构：
[1] Saiseikai Kumamoto Hosp, Kumamoto, Japan
[2] Kumamoto Univ, Kumamoto, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic models for cardiovascular events after successful primary percutaneous coronary intervention
    Synetos, A.
    Toutouzas, K.
    Karanasos, A.
    Nikolaou, C.
    Michelongona, A.
    Tsiamis, E.
    Tousoulis, D.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2012, 33 : 501 - 501
  • [42] Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes
    Steg, PG
    Lung, B
    Feldman, LJ
    Cokkinos, D
    Deckers, J
    Fox, KAA
    Keil, U
    Maggioni, AP
    HEART, 2002, 88 (01) : 20 - 24
  • [43] ATHEROSCLEROSIS REGRESSION, PLAQUE DISRUPTION, AND CARDIOVASCULAR EVENTS - A RATIONALE FOR LIPID LOWERING IN CORONARY-ARTERY DISEASE
    BROWN, BG
    ZHAO, XQ
    SACCO, DE
    ALBERS, JJ
    ANNUAL REVIEW OF MEDICINE, 1993, 44 : 365 - 376
  • [44] ASPIRIN RESISTANCE IS A RISK FACTOR FOR NON-FATAL CORONARY EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTIONS
    Catakoglu, A. B.
    Aytekin, S.
    Celebi, H.
    Sener, M.
    Kurtoglu, H.
    Demiroglu, I. C. C.
    Aytekin, V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 3 - 3
  • [45] Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid-lowering therapy
    Yamamoto, Hiroyuki
    Shinke, Toshiro
    Otake, Hiromasa
    Kawamori, Hiroyuki
    Toba, Takayoshi
    Kuroda, Masaru
    Hirota, Yushi
    Sakaguchi, Kazuhiko
    Ogawa, Wataru
    Hirata, Ken-ichi
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (06) : 1015 - 1024
  • [46] Complications Related to Access Site After Percutaneous Coronary Interventions: Are the Adverse Events Underreported?
    Crudu, Vitalie
    Blankenship, James
    Berger, Peter
    Scott, Thomas
    Skelding, Kimberly
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2011, 77 (05) : 643 - 647
  • [47] Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in diabetic patients
    Briguori, C
    Condorelli, G
    Airoldi, F
    Mikhail, GW
    Ricciardelli, B
    Colombo, A
    HEART, 2004, 90 (12) : 1481 - 1482
  • [48] Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions
    Argulian, Edgar
    Patel, Amar D.
    Abramson, Jerome L.
    Kulkarni, Aniket
    Champney, Kimberly
    Palmer, Spencer
    Weintraub, William
    Wenger, Nanette K.
    Vaccarino, Viola
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (01): : 48 - 53
  • [49] The real-world prevalence of cardiovascular events related to coronary spasm after percutaneous coronary intervention
    Hokimoto, Seiji
    Tabata, Noriaki
    Sueta, Daisuke
    Akasaka, Tomonori
    Tsujita, Kenichi
    Sakamoto, Kenji
    Kaikita, Koichi
    Kojima, Sunao
    Ogawa, Hisao
    JOURNAL OF CARDIOLOGY, 2016, 68 (1-2) : 20 - 28
  • [50] Comparison of Cardiovascular Events by Different Types of Lipid-Lowering Drugs in Kidney Transplant Recipients.
    Bae, S.
    Ahn, J.
    Schnitzler, M. A.
    Lentine, K.
    Segev, D.
    McAdams-DeMarco, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 683 - 684
12345